Wu CE, Tzen CY, Wang SY, Yeh CN. Clinical diagnosis of gastrointestinal stromal tumor (GIST): from the molecular genetic point of view. Cancers (Basel). 2019;11(5):679.

van de Wal D, Elie M, Le Cesne A, Fumagalli E, den Hollander D, Jones RL, et al. Health-related quality of life and side effects in gastrointestinal stromal tumor (GIST) patients treated with tyrosine kinase inhibitors: a systematic review of the literature. Cancers (Basel). 2022;14(7):1832.

Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46.

Article  PubMed  Google Scholar 

Obata Y, Horikawa K, Takahashi T, Akieda Y, Tsujimoto M, Fletcher JA, et al. Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors. Oncogene. 2017;36(26):3661–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma C, Tsai H, Su W, Sun L, Shih Y, Wang J. Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): a prospective, randomized, double-blind study. J Postgrad Med. 2018;64(3):155–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265–74.

Article  PubMed  Google Scholar 

Xue A, Gao X, Fang Y, Shu P, Ling J, Shen K, et al. Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors. Acta Biochim Biophys Sin (Shanghai). 2017;49(2):179–85.

Article  CAS  PubMed  Google Scholar 

Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016;19(1):3–14.

Article  CAS  PubMed  Google Scholar 

Pang T, Zhao Y, Fan T, Hu Q, Raymond D, Cao S, et al. Comparison of safety and outcomes between endoscopic and surgical resections of small (≤ 5 cm) primary gastric gastrointestinal stromal tumors. J Cancer. 2019;10(17):4132–41.

Article  PubMed  PubMed Central  Google Scholar 

Zong L, Chen P, Xu Y. Correlation between P53 expression and malignant risk of gastrointestinal stromal tumors: evidence from 9 studies. Eur J Surg Oncol. 2012;38(3):189–95.

Article  CAS  PubMed  Google Scholar 

Hu TH, Chuah SK, Lin JW, Chiu YC, Changchien CS, Wang CC, et al. Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese. World J Gastroenterol. 2006;12(4):595–602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu TH, Lin JW, Changchien CS, Liu SY, Chiou SS, Chuang JH. Immunohistochemical analyses of gastric stromal tumors in Taiwanese. J Formos Med Assoc. 2003;102(10):707–14.

PubMed  Google Scholar 

Zong L, Chen P. Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. World J Surg Oncol. 2014;12:71.

Article  PubMed  PubMed Central  Google Scholar 

Kwon MS, Koh JS, Lee SS, Chung JH, Ahn GH. Fine needle aspiration cytology (FNAC) of gastrointestinal stromal tumor: an emphasis on diagnostic role of FNAC, cell block, and immunohistochemistry. J Korean Med Sci. 2002;17(3):353–9.

Article  PubMed  PubMed Central  Google Scholar 

Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.

Article  PubMed  Google Scholar 

Maehara Y, Kakeji Y, Oda S, Baba H, Sugimachi K. Tumor growth patterns and biological characteristics of early gastric carcinoma. Oncology. 2001;61(2):102–12.

Article  CAS  PubMed  Google Scholar 

Sui C, Lin C, Tao T, Guan W, Zhang H, Tao L, et al. Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors. BMC Gastroenterol. 2023;23(1):25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Liu Q. Prognostic indicators for gastrointestinal stromal tumors: a review. Transl Oncol. 2020;13(10):100812.

Article  PubMed  PubMed Central  Google Scholar 

Davila RE. A gastroenterologist’s approach to the diagnosis and management of gastrointestinal stromal tumors. Gastroenterol Clin North Am. 2022;51(3):609–24.

Article  PubMed  Google Scholar 

Shibata T, Koyama K, Yamada H, Kawamura T, Yoshida D, Osaki H, et al. The association between the growth pattern and malignancy in the formation of ulceration in gastric gastrointestinal stromal tumor. Intern Med. 2023;0983-22.

Nishida T, Kawai N, Yamaguchi S, Nishida Y. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc. 2013;25(5):479–89.

Article  PubMed  Google Scholar 

Tanabe K, Urabe Y, Tokumoto N, Suzuki T, Yamamoto H, Oka S, et al. A new method for intraluminal gastrointestinal stromal tumor resection using laparoscopic seromuscular dissection technique. Dig Surg. 2010;27(6):461–5.

Article  PubMed  Google Scholar 

Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, et al. AIDS-related Kaposi sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(2):171–89.

Article  PubMed  Google Scholar 

Zhou Y, Hu W, Chen P, Abe M, Shi L, Tan SY, et al. Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(34):e7911.

Article  CAS  PubMed  Google Scholar 

Gumurdulu D, Erdogan S, Kayaselcuk F, Seydaoglu G, Parsak CK, Demircan O, et al. Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters. World J Gastroenterol. 2007;13(3):426–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pyo JS, Kang G, Sohn JH. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis. Int J Biol Markers. 2016;31(2):e204–10.

Article  PubMed  Google Scholar 

Neppala P, Banerjee S, Fanta PT, Yerba M, Porras KA, Burgoyne AM, et al. Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors. Cancer Metastasis Rev. 2019;38(3):525–35.

Article  CAS  PubMed  PubMed Central  Google Scholar